• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Smoking Increases Risk of Inverted Papilloma Recurrence

by John Del Gaudio, MD • December 1, 2010

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

What clinical and environmental factors can predict recurrence or malignant transformation of sinonasal inverted papilloma (IP)?

You Might Also Like

  • Surveillance Recommendations Following Resection of Sinonasal Inverted Papilloma
  • Secondhand Smoke Increases Chronic Rhinosinusitis Risk
  • Analysis of Five-Year Recurrence Patterns in Sinonasal Cancer
  • Exploring Links Between Smoking, Diet, and Oral Cancer Risk: What Should Be Message to Patients?
Explore This Issue
December 2010

Background: IP is a benign neoplasm that is locally aggressive, with a less than 10 percent recurrence rate and potential for malignant transformation. Few studies have reported the effects of environmental factors, especially cigarette smoking, on recurrence rates of IP.

Study design: Retrospective study of patients who had primary surgery for IP at a single university

Setting: Seoul National University Hospital, Seoul, South Korea

Synopsis: The study included 132 patients with IP over a 22-year period. Recurrence rates were significantly higher in patients with a smoking history and for those patients with Krouse stage IV tumors (extranasal/extrasinus extension). Average time to recurrence was 48.3 months. Recurrence rates were not affected by a history of diabetes mellitus, hypertension or allergic rhinitis. Malignant transformation was more likely in Krouse stage III (5/72, 6.9 percent) and especially stage IV tumors (3/3, 100 percent).

Because this is a retrospective study, there are limitations on smoking data acquisition. Smoking history was identified but could not be quantified as to extent of smoking history (i.e., pack years) and whether patients smoked at the time of resection or recurrence. All three patients with stage IV tumors had malignant transformation, but this is a small number.

Bottom line: A history of smoking increased the risk of recurrence of IP. Also, tumors at a more advanced stage were more likely to undergo malignant transformation. Because the average time to recurrence was 48.3 months, long-term postoperative follow-up is necessary for patients after IP resection.

Citation: Moon IJ, Lee DY, Suh MW, et al. Cigarette smoking increases risk of recurrence for sinonasal inverted papilloma. Am J Rhinol Allergy. 2010;24(5):325-329.

—Reviewed by John Del Gaudio, MD

Filed Under: Literature Reviews, Rhinology Tagged With: clinical, IP, malignant, sinonasal inverted papillomaIssue: December 2010

You Might Also Like:

  • Surveillance Recommendations Following Resection of Sinonasal Inverted Papilloma
  • Secondhand Smoke Increases Chronic Rhinosinusitis Risk
  • Analysis of Five-Year Recurrence Patterns in Sinonasal Cancer
  • Exploring Links Between Smoking, Diet, and Oral Cancer Risk: What Should Be Message to Patients?

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you successfully navigated a mid-career change?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • ENTtoday Welcomes Resident Editorial Board Members
  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Popular this Week
  • Most Popular
  • Most Recent
    • Empty Nose Syndrome: Physiological, Psychological, or Perhaps a Little of Both?

    • Physician, Know Thyself! Tips for Navigating Mid-Career Transitions in Otolaryngology

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • ENTtoday Welcomes Resident Editorial Board Members
    • Journal Publishing Format Suggestion: A Greener Future for Medical Journals
    • Physician, Know Thyself! Tips for Navigating Mid-Career Transitions in Otolaryngology
    • PA Reform: Is the Administrative War of Attrition Ending?
    • How To: Anatomic-Based Technique for Sensing Lead Placement in Hypoglossal Stimulator Implantation

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939